logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

复星国际 金徽酒

Fosun Int’l Bets on China’s Unquenchable Thirst via Majority Stake in Jinhui Liquor

May 27, 2020

Life Science

博雅辑因和艺妙神州

EdiGene and Immunochina Announce Research and Development Collaboration to Develop Allogeneic CAR-T Therapy for Cancer

May 27, 2020

Life Science

Healthcare Roundup – PhaseBio gets FDA OK for clinical trial of COVID-19 treatment, Moderna correction pressures COVID-19 vaccine developers

May 27, 2020

Life Science

Naturally Splendid Announces Clinical Trial Application Submitted to Health Canada for Phase 2 COVID 19 Clinical Trial  

May 26, 2020

Life Science

Healthcare Roundup – Novavax starts clinical trial of COVID-19 vaccine, Sanofi to shed 20.6% stake in Regeneron

May 25, 2020

Life Science

有效控制糖尿病,拜耳与WaveForm为中国带来血糖监测方案

Bayer, WaveForm in tie-up for glucose monitoring solutions for China

May 25, 2020

Life Science

医疗保健精选——FDA批准武田药品的brigatinib,辉瑞敦促票据持有人拒绝Huguenot Bond Liquidity的报价

Healthcare Roundup – FDA OKs Takeda’s brigatinib, Pfizer urges noteholders to reject offer by Huguenot Bond Liquidity

May 23, 2020

Life Science

中国冠科美博启动肿瘤疗法APL-101的全球多中心试验

Apollomics, Inc. Announces Initiation of SPARTA Phase 2 Clinical Trial for c-MET Inhibitor APL-101

May 22, 2020

Life Science

中國康希諾生物新冠疫苗領跑全球!

CanSino Publishes Phase I Data for COVID-19 Vaccine Candidate, Moves into Phase II

May 22, 2020

Life Science

中国科兴获投资,加速COVID-19疫苗开发

Sinovac Secures $15 Million in Funding to Accelerate COVID-19 Vaccine Development

May 22, 2020

Life Science

中国安科生物免洗洗手液获美国市场准入许可

Anke Biotech Gets Nod to Sell Hand Sanitizer in US  

May 22, 2020

Life Science

北京大学北大高活性新冠病毒中和抗体

Peking Uni Researchers Expect to Crack Covid-19 Treatment This Winter

May 22, 2020

Life Science

Walmax’s Pneumonia Jab for Kids Goes to Market in China, Ending Pfizer Monopoly

May 22, 2020

Life Science

医疗保健精选——雅培用积极数据回应纽约大学研究结论,罗氏和雅培签署了COVID-19测试协议

Healthcare Roundup – Abbott buries NY study with positive data, Roche and Abbott land COVID-19 test deal

May 21, 2020

Life Science

I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme

May 21, 2020

Life Science

Naturally Splendid Enterprises Ltd TSXV:NSP Biotechnology, Nutraceutical, Consumer Products and Services, 生物科技,营养品,消费品,

Naturally Splendid Provides Update for Phase 2 COVID 19 Clinical Trial

May 21, 2020

Life Science

医疗保健精选——Aurora Cannabis借收购进军美国市场,Inovio发表COVID-19疫苗数据,股价上涨

Healthcare Roundup – Aurora Cannabis entering U.S. market with acquisition, Inovio rallies on COVID-19 vaccine data

May 20, 2020

Life Science

造福千上万心梗患者,中国青岛普美圣医药签约加拿大药企

Qingdao Primedicine Pharmaceutical Co. Ltd and Primary Peptides Inc. Announce Exclusive China Partnership

May 20, 2020

Life Science

  • ‹‹ Previous
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada